CrushSCI.com
Journal Selection & Manuscript Polishing Services
Cancers journal cover Medicine
Back to journal directory

Review Cycle Records

Cancers

MDPI SCIE OA
2026 Emerging Zone 22025 CAS Zone 32025 JCR Q2
45.3Average days
38Median days
18Fastest days
107Longest days
4,0842025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

26 days

Integrated Transcriptomic Analysis Reveals Coordinated Gliovascular Remodeling Across Diffuse Glioma Grades

AuthorsJuliAnne E. Allgood; Kaitlyn Miller; Lindsey Burnsed; Jessica E. Pullan

Affiliations1. College of Osteopathic Medicine, Rocky Vista University, Ivins, UT 84738, USA; 2. Department of Chemistry and Physics, Southern Utah University, Cedar City, UT 84720, USA

Source PDF DOI Publisher page
30 days

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy

AuthorsLinda Bartalini; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Angela Lamarca; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Jeroen Dekervel; Chiara Braconi; David James Pinato; Emiliano Tamburini; Chiara Carlotta Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Yung-Yeh Su; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Andrea Pretta; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Lorenzo Fornaro; Andrea Casadei-Gardini; Lorenza Rimassa

Affiliations1. Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy; 2. IRCCS San Raffaele Hospital, 20132 Milan, Italy; 3. Vita-Salute San Raffaele University, 20132 Milan, Italy; 4. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa 277-8577, Japan; 5. Department of Internal Medicine, Mayo Clinic, Phoenix, AZ 85054, USA; 6. Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy; 7. Clinical Oncology Unit, Careggi University Hospital, 50134 Florence, Italy; 8. Department of Experimental and Clinical Medicine, University of Florence, 50139 Florence, Italy; 9. Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam 13620, Republic of Korea; 10. Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology, Hannover Medical School, 30625 Hannover, Germany; 11. Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Schwartz Reisman Liver Research Centre, Toronto ON M5G 2C4, Canada; 12. Department of Medical Oncology, FJD Comprehensive Cancer Centre, ENETS Centre of Excellence (GEP and Lung)—Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain; 13. Fundación Jiménez Díaz University Hospital, Health Research Institute Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), 28040 Madrid, Spain; 14. Oncology 1 Unit, Department of Medical Oncology, Veneto Institute of Oncology IOV—IRCCS, 35128 Padua, Italy; 15. Hepatopancreatobiliary Oncology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy; 16. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56124 Pisa, Italy; 17. Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy; 18. Digestive Oncology, University Hospitals Leuven, 3000 Leuven, Belgium; 19. School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK; 20. Beatson West of Scotland Centre, Glasgow G12 0YN, UK; 21. CRUK Scotland Centre, Glasgow G61 1BD, UK; 22. Department of Surgery&Cancer, Imperial College London, Hammersmith Hospital, London W12 0NN, UK; 23. Department of Oncology and Palliative Care, Cardinale G. Panico, Tricase City Hospital, 73039 Tricase, Italy; 24. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy; 25. Santa Maria Delle Croci Hospital of Ravenna, AUSL Romagna, 48121 Ravenna, Italy; 26. Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy; 27. Upper Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, 08035 Barcelona, Spain; 28. UOC Oncologia A, Department of Hematology, Oncology and Dermatology, Policlinico Umberto I, Sapienza University of Rome, 04019 Rome, Italy; 29. Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica Delle Marche, Azienda Ospedaliero-Universitaria Delle Marche, 60126 Ancona, Italy; 30. Digestive Unit, Champalimaud Clinical Centre, Champalimaud Research Centre Champalimaud Foundation, 1400-038 Lisbon, Portugal; 31. Division of Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea; 32. Department of Medical Oncology, OECI Comprehensive Cancer Centre—ENETS Centre of Excellence (GEP and Lung)—Fundacion Jimenez Diaz University Hospital, Health Research Institute Fundación Jiménez Díaz (IIS-FJD), 28040 Madrid, Spain; 33. Medical Oncology and Biomedical Therapy, Policlinico Riuniti, 71122 Foggia, Italy; 34. Medical Clinic 1, University Hospital, Goethe-University Frankfurt, 60590 Frankfurt am Main, Germany; 35. Dipartimento di Oncologia medica, Fondazione Poliambulanza, 25124 Brescia, Italy; 36. Clinical Experimental Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS Fondazione G. Pascale, 80131 Naples, Italy; 37. IRCCS Istituto Nazionale Tumori Regina Elena, 00138 Roma, Italy; 38. Internal Medicine 1, University Hospital Ulm, 89081 Ulm, Germany; 39. Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, 89081 Ulm, Germany; 40. Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Republic of Korea; 41. Oncologia Medica, Dipartimento di Medicina dei Sistemi, Università di Tor Vergata, 00133 Roma, Italy; 42. Department of Medical Oncology, Unidade Local de Saude do Algarve (ULSAlg), 8000-286 Faro, Portugal; 43. Medical Oncology Unit, University Hospital of Parma, Parma 43126, Italy; 44. Oncology Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy; 45. Department of Internal Medicine and Medical Therapy, University of Pavia, 27100 Pavia, Italy; 46. Division of Medical Oncology, Candiolo Cancer Institute IRCCS, 10060 Turin, Italy; 47. Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, 10043 Turin, Italy; 48. Medical Oncology, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy; 49. Oncology Unit, Ospedale del Mare, 80147 Napoli, Italy; 50. ASAN Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea; 51. Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, 01100 Viterbo, Italy; 52. Oncology Unit, Fondazione IRCCS “Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy; 53. Medical Oncology, University Hospital and University of Cagliari, 09042 Cagliari, Italy; 54. GI Oncology Unit and Familial Cancer Unit, Oncology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain; 55. Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; 56. Department of Medicine I, Clinical Division of Oncology, Medical University Vienna, 1090 Vienna, Austria; 57. Department of Medical Oncology, AULSS 8 Berica, 36110 Vicenza, Italy; 58. UOC Oncologia Territoriale, Polo Pontino, La Sapienza Università Di Roma, 04100 Latina, Italy; 59. National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan; 60. Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan; 61. Department of Clinical Oncology, Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong SAR, China; 62. Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK; 63. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy

Source PDF DOI Publisher page
31 days

IL1β Functions as a Tumor Suppressor in Papillary Thyroid Carcinoma via the SMDT1-MAPK Signaling Axis

AuthorsTenghong Liu; Liyong Zhang; Zhijun Chen; Shaojun Cai; Wenxin Zhao

Affiliations1. Department of Thyroid Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China

Source PDF DOI Publisher page
35 days

Impact of 18F-DCFPyL-PSMA PET/CT on Radiotherapy Planning and Treatment Intensification in Occult Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy

AuthorsFrancesco Amorelli; Pedro Plaza; Augusto Natali; Juan Sebastian Blanco; Xavier Duran; Palmira Foro

Affiliations1. Department of Radiation Oncology, Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, 08908 Barcelona, Spain; 2. Ph.D. Program, Doctoral School, Pompeu Fabra University, 08002 Barcelona, Spain; 3. Department of Nuclear Medicine, Hospital del Mar, 08003 Barcelona, Spain; 4. Department of Laboratory Medicine, CLILAB Diagnostics, Hospitalet de Llobregat, 08906 Barcelona, Spain; 5. Medical Statistics Unit (MSU) MARData, Hospital del Mar, 08003 Barcelona, Spain; 6. Department of Radiation Oncology, Hospital del Mar, 08003 Barcelona, Spain

Source PDF DOI Publisher page
38 days

Clinical and Radiologic Features Correlated with Eye-Sparing Surgery vs. Orbital Exenteration for Lacrimal Gland Adenoid Cystic Carcinoma †

AuthorsBita Esmaeli; Yunyi Wang; Tracy Lu; Jing Ning; Amy C. Moreno; Steven J. Frank; Luana G. Sousa; Renata Ferrarotto; J. Matthew Debnam

Affiliations1. Department of Ophthalmology, Houston Methodist Hospital Academic Institute, Houston, TX 77030, USA; 2. Oncologic Ophthalmic Plastic & Orbital Surgery, Mann Eye Institute, Houston, TX 77004, USA; 3. Department of Clinical Sciences, University of Houston Tilman J. Fertitta Family College of Medicine, Houston, TX 77001, USA; 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 5. Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 6. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 7. Department of Head and Neck & Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 8. Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Source PDF DOI Publisher page
40 days

Line-Field Confocal Optical Coherence Tomography as a Follow-Up Tool for 3D-Printed HDR Surface Brachytherapy of Cutaneous Squamous Cell Carcinoma: A Proof-of-Concept Study at Short-Term (Six-Month) Follow-Up

AuthorsPiotr Sobolewski; Mateusz Koper; Michal Poltorak; Pawel Banatkiewicz; Malgorzata Kolos; Lukasz Poltorak; Maciej Szwast; Irena Walecka

Affiliations1. The National Medical Institute of the Ministry of the Interior and Administration, Woloska 137, 02-507 Warsaw, Poland; 2. Chair and Clinic of Dermatology and Pediatric Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland; 3. Electrochemistry at Soft Interfaces Team, Department of Inorganic and Analytical Chemistry, Faculty of Chemistry, University of Lodz, Tamka 12, 91-403 Lodz, Poland; 4. Department of Chemical and Process Engineering, Warsaw University of Technology, Warynskiego 1, 00-645 Warsaw, Poland

Source PDF DOI Publisher page
41 days

Changes in C-Reactive Protein Forecast Infection Risk Following Treatment with Chimeric Antigen Receptor T Cells

AuthorsPoonam Mathur; Hegang Chen; David J. Riedel; Elizabeth Holland; Danica Palacio; Jacqueline T. Bork; Katya Prakash; Nancy Hardy; Mehmet Kocoglu; Ashraf Badros; Ariel Fromowitz; Jean Yared; Aaron P. Rapoport; Djordje Atanackovic; John Baddley

Affiliations1. Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; 3. Zucker School of Medicine, Northwell Health, Manhasset, NY 11030, USA; 4. University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, USA; 5. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Source PDF DOI Publisher page
41 days

First-Line Immune Checkpoint Inhibitors in Older Patients with Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis

AuthorsDalila Incognito; Andrea D’Arienzo; Sergio Facchini; Chiara Barraco; Antonio Picone; Antonella Nicastro; Giuliana Ciappina; Giordana Di Mauro; Antonio Ieni; Massimiliano Berretta; Gaetano Facchini

Affiliations1. Medical Oncology Unit, Department of Human Pathology “G. Barresi”, School of Specialization in Medical Oncology, University of Messina, 98122 Messina, Italy; 2. Translational Molecular Medicine and Surgery, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; 3. Oncology Unit, “Santa Maria Delle Grazie” Hospital, 80078 Pozzuoli, Italy; 4. Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy; 5. Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; 6. Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy; 7. Applied Biology and Experimental Medicine, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy; 8. Department of Human Pathology of Adult and Childhood “Gaetano Barresi”, University of Messina, 98121 Messina, Italy; 9. Division of Medical Oncology, “G. Martino” University Hospital, University of Messina, 98124 Messina, Italy

Source PDF DOI Publisher page
44 days

SBRT for Colorectal Cancer Liver Metastasis Is a Safe and Effective Treatment Option—A Single Institution Retrospective Analysis

AuthorsNitsan Peled Oved; Marc Wygoda; Adi Levy; Mor Oved; Philip Blumenfeld; Ayala Hubert; Aron Popovtzer; Tamar Peretz; Aviad Zick; Tal Falick Michaeli

Affiliations1. Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel; 2. Department of Military Medicine and “Tzamert”, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel; 3. Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel

Source PDF DOI Publisher page
83 days

Functionally Informed Hand Knob Reveals Structural Connectome Differences in Motor-Eloquent Tumours

AuthorsSankhya Prakashvel; Filippo Sinosi; Laura Ferrari; Feras Fayez; Sabina Patel; Yasir A. Chowdhury; Andrea Perera; Nida Kalyal; Mariam Awan; Alba Diaz-Baamonde; Ana Mirallave-Pescador; Keyoumars Ashkan; Ranjeev Bhangoo; Francesco Vergani; Jose Pedro Lavrador

Affiliations1. Queens’ Hospital Romford, London RM7 0AG, UK; 2. King’s College Hospital, London SE5 9RS, UK; 3. University College London Hospital, London NW1 2BU, UK

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.